Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical Trial

Eva Román, Cristina García-Galcerán, Teresa Torrades, Silvia Herrera, Ana Marín, Maite Doñate, Edilmar Alvarado-Tapias, Jorge Malouf, Laura Nácher, Ricard Serra-Grima, Carlos Guarner, Juan Cordoba, German Soriano, Eva Román, Cristina García-Galcerán, Teresa Torrades, Silvia Herrera, Ana Marín, Maite Doñate, Edilmar Alvarado-Tapias, Jorge Malouf, Laura Nácher, Ricard Serra-Grima, Carlos Guarner, Juan Cordoba, German Soriano

Abstract

Patients with cirrhosis often have functional limitations, decreased muscle mass, and a high risk of falls. These variables could improve with exercise. The aim was to study the effects of moderate exercise on functional capacity, body composition and risk of falls in patients with cirrhosis. Twenty-three cirrhotic patients were randomized to an exercise programme (n = 14) or to a relaxation programme (n = 9). Both programmes consisted of a one-hour session 3 days a week for 12 weeks. At the beginning and end of the study, we measured functional capacity using the cardiopulmonary exercise test, evaluated body composition using anthropometry and dual energy X-ray absorptiometry, and estimated risk of falls using the Timed Up&Go test. In the exercise group, cardiopulmonary exercise test showed an increase in total effort time (p<0.001) and ventilatory anaerobic threshold time (p = 0.009). Upper thigh circumference increased and mid-arm and mid-thigh skinfold thickness decreased. Dual energy X-ray absorptiometry showed a decrease in fat body mass (-0.94 kg, 95%CI -0.48 to -1.41, p = 0.003) and an increase in lean body mass (1.05 kg, 95%CI 0.27 to 1.82, p = 0.01), lean appendicular mass (0.38 kg, 95%CI 0.06 to 0.69, p = 0.03) and lean leg mass (0.34 kg, 95%CI 0.10 to 0.57, p = 0.02). The Timed Up&Go test decreased at the end of the study compared to baseline (p = 0.02). No changes were observed in the relaxation group. We conclude that a moderate exercise programme in patients with cirrhosis improves functional capacity, increases muscle mass, and decreases body fat and the Timed Up&Go time.

Trial registration: ClinicalTrials.gov NCT01447537.

Conflict of interest statement

Competing Interests: Specifically, the authors do not have any competing interest with Decathlon Foundation, and the funding the authors received from Decathlon Foundation does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1. Flowchart of the study.
Fig 1. Flowchart of the study.
Fig 2. Changes in body composition by…
Fig 2. Changes in body composition by dual energy X-ray absorptiometry (DXA) between baseline and end of the study in patients from the exercise group.
Results are expressed as difference and 95%CI.
Fig 3
Fig 3
Correlations between changes in anthropometric measurements and changes in body composition assessed by dual energy x-ray absorptiometry (DXA): (A) mid-arm skinfold thickness and fat body mass, (B) upper thigh circumference and lean leg mass. Results are expressed as % change.
Fig 4. Risk of falls evaluated using…
Fig 4. Risk of falls evaluated using the Timed Up&Go test at baseline and at the end of the study (12 weeks) in both groups.
Results are expressed as mean±standard error of the mean.

References

    1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–423. 10.1093/ageing/afq034
    1. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10:166–173. 10.1016/j.cgh.2011.08.028
    1. Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol. 2014;20:8061–8071. 10.3748/wjg.v20.i25.8061
    1. Lucero C, Verna EC. The role of sarcopenia and frailty in hepatic encephalopathy management. Clin Liver Dis. 205;19:507–528.
    1. Jones JC, Coombes JS, Macdonald GA. Exercise capacity and muscle strength in patients with cirrhosis. Liver Transpl. 2012;18:146–151. 10.1002/lt.22472
    1. Kachaamy T, Bajaj JS, Heuman DM. Muscle and mortality in cirrhosis. Clin Gastroenterol Hepatol. 2012;10:100–102. 10.1016/j.cgh.2011.11.002
    1. Pieber K, Crevenna R, Nuhr MJ, Quittan M, Peck-Radosavljevic M, Fialka-Moser V, et al. Aerobic capacity, muscle strength and health-related quality of life before and after orthotopic liver transplantation: preliminary data of an Austrian transplantation centre. J Rehabil Med. 2006;38:322–328.
    1. Les I, Doval E, Flavià M, Jacas C, Cárdenas G, Esteban R, et al. Quality of life in cirrhosis is related to potentially treatable factors. European J Gastroenterol Hepatol. 2010;22:221–227.
    1. Carey EJ, Steidley DE, Aqel BA, Byrne TJ, Mekeel KL, Rakela J, et al. Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transpl. 2010;16:1373–1378. 10.1002/lt.22167
    1. Román E, Córdoba J, Torrens M, Torras X, Villanueva C, Vargas V, et al. Minimal hepatic encephalopathy is asociated with falls. Am J Gastroenterol. 2011;106:476–482. 10.1038/ajg.2010.413
    1. Soriano G, Román E, Córdoba J, Torrens M, Poca M, Torras X, et al. Cognitive dysfunction is associated with falls. A prospective study. Hepatology. 2012;55:1922–1930. 10.1002/hep.25554
    1. Hunter GR, McCarthy JP, Bamman MM. Effects of resistance training on older adults. Sports Med. 2004;34:329–348.
    1. Tabet JY, Meurin P, Driss AB, Weber H, Renaud N, Grosdemouge A, et al. Benefits of exercise training in chronic heart failure. Arch Cardiovasc Dis. 2009;102:721–730. 10.1016/j.acvd.2009.05.011
    1. Segura-Orti E, Johansen KL. Exercise in end-stage renal disease. Semin Dial. 2010;23:422–430. 10.1111/j.1525-139X.2010.00766.x
    1. Dereli EE, Yaliman A. Comparison of the effects of a physiotherapist-supervised exercise programme and a self-supervised exercise programme in quality of life in patients with Parkinson’s disease. Clin Rehabil. 2010;24:352–362. 10.1177/0269215509358933
    1. García-Pagán JC, Santos C, Barberá JA, Luca A, Roca J, Rodriguez-Roisin R, et al. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology. 1996;111:1300–1306.
    1. Bandi JC, García-Pagán JC, Escorsell A, François E, Moitinho E, Rodés J, et al. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology. 1998; 28:677–682.
    1. Saló J, Guevara M, Fernández-Esparrach G, Bataller R, Ginès A, Jimenez W, et al. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems. Hepatology. 1997;25:1338–1342.
    1. Román E, Torrades MT, Nadal MJ, Cárdenas G, Nieto JC, Vidal S, et al. Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis. Dig Dis Sci. 2014;59:1966–1975. 10.1007/s10620-014-3086-6
    1. Zenith L, Meena N, Ramadi A, Yavari M, Harvey A, Carbonneau M, et al. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol. 2014;12:1920–1926. 10.1016/j.cgh.2014.04.016
    1. Debette-Gratien M, Tabouret T, Antonini MT, Dalmay F, Carrier P, Legros R, et al. Personalized adapted physical activity before liver transplantation: acceptability and results. Transplantation. 2015;99:145–150. 10.1097/TP.0000000000000245
    1. Berzigotti A, Saran U, Dufour JF. Physical activity and liver diseases. Hepatology. 2015. August 27 10.1002/hep.28132 [Epub ahead of print].
    1. El-Khoury F, Cassou B, Charles MA, Dargent-Molina P. The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults: systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f6234 10.1136/bmj.f6234
    1. Steindorf K, Schmidt ME, Klassen O, Ulrich CM, Oelmann J, Habermann N, et al. Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life. Ann Oncol 2014;25: 2237–2243. 10.1093/annonc/mdu374
    1. ATS statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. Am J Respir Crit Care Med. 2002;166:111–117.
    1. Lukaski H. Sarcopenia: assessment of muscle mass. J Nutr. 1997;127(5Suppl):994S–997S.
    1. Wang J, Thornton JC, Kolesnik S, Pierson RN Jr. Anthropometry in body composition. An overview. Ann N Y Acad Sci. 2000;904:317–326.
    1. Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, et al. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012;126:2261–2274. 10.1161/CIR.0b013e31826fb946
    1. Wasserman K. Clinical applications of cardiopulmonary exercise testing In: Principles of Exercise Testing and Interpretation, Fifth ed., Philadelphia, PA, USA: Lippincott Williams & Wilkins; 2012, chapter 9.
    1. Viccaro LJ, Perera S, Studenski SA. Is timed up and go better than gait speed in predicting health, function, and falls in older adults? J Am Geriatr Soc. 2011;59:887–892. 10.1111/j.1532-5415.2011.03336.x
    1. Piña IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, et al. Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation. 2003;107:1210–1225.
    1. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173:1390–1413.
    1. Centers for Disease Control and Prevention. Target heart rate and estimated maximum heart rate. Atlanta, GA, USA, 2011. Available: .
    1. Caycedo N, Carsí Costas N, Van Rangelrooy K. Sophrology. Rev Enferm. 2005;28:30–38.
    1. Berzigotti A, García-Tsao G, Bosch J, Grace ND, Burroughs AK, Morillas R, et al. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology. 2011;54:555–561. 10.1002/hep.24418
    1. Berzigotti A, Villanueva C, Genescà J, Ardevol A, Augustín S, Calleja JL, et al. Lifestyle intervention by a 16-week programme of supervised diet and physical exercise ameliorate portal hypertension in patients with cirrhosis and obesity: the SportDiet study. Hepatology. 2014;60(suppl.4):253A (abstract).
    1. Tsai CF, Liu CJ, Chen TJ, Chu CJ, Lin HC, Lee FY, et al. Increased incidence of orthopedic fractures in cirrhotic patients: a nationwide population-based study. J Hepatol. 2013;58:706–714. 10.1016/j.jhep.2012.12.001
    1. Román E, Córdoba J, Torrens M, Guarner C, Soriano G. Falls and cognitive dysfunction impair health-related quality of life in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2013;25:77–84. 10.1097/MEG.0b013e3283589f49

Source: PubMed

3
購読する